Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
The S&P 500's top 10 performers since its bear market low — and where Cramer stands on them now
October 13, 2023
From CNBC.com News
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
From CNBC.com News
3 moments from October's Monthly Meeting of the CNBC Investing Club with Jim Cramer
October 11, 2023
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
From CNBC.com News
Tickers
CEO
From CNBC.com News
From CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
From CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
October 05, 2023
From CNBC.com News
From CNBC.com News
Stocks making the biggest moves premarket: Warby Parker, HP, Point Biopharma and more
October 03, 2023
From CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
From CNBC.com News
From CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
September 19, 2023
From CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
September 11, 2023
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
From CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
From CNBC.com News
From CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
September 07, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
From CNBC.com News
This biotech name is one of Jim Cramer's favorite stocks and he thinks it can go even higher
August 21, 2023
From CNBC.com News
Redwire and Sierra team up to make drugs in space on inflatable habitat’s first mission
August 21, 2023
From CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
August 17, 2023
From CNBC.com News
Cramer points out stocks to watch as China's economy slows down
August 15, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
